US 11951212
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
granted A61KA61K31/404A61K31/443
Quick answer
US patent 11951212 (Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/404, A61K31/443, A61K31/47, A61K31/4709